Chromosomes 1p And 19q - Histology

Relevant Publications

Oligodendrocyte-specific expression of - suggests a role in myelination with prognostic value in oligodendroglioma.

Issue Release: 2024

Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, Gene Expression Profile and Patient Outcome.

Issue Release: 2024

In-house molecular diagnosis of diffuse glioma updating the revised WHO classification by a platform of the advanced medical care system, Senshin-Iryo.

Issue Release: 2024

NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway.

Issue Release: 2024

Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy.

Issue Release: 2023

Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using F-FET PET.

Issue Release: 2023

Efficient diagnosis of IDH-mutant gliomas: 1p/19qNET assesses 1p/19q codeletion status using weakly-supervised learning.

Issue Release: 2023

Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.

Issue Release: 2022

Recurrent oligodendroglioma with changed 1p/19q status.

Issue Release: 2022

Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing.

Issue Release: 2022

Abstracts of Presentations at the Association of Clinical Scientists 143 Meeting Louisville, KY May 11-14,2022.

Issue Release: 2022

Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.

Issue Release: 2022

Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.

Issue Release: 2022

[Histomolecular diagnosis of glial and glioneuronal tumours].

Issue Release: 2021

IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.

Issue Release: 2021

Multi-institutional noninvasive in vivo characterization of , 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk).

Issue Release: 2021

Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer.

Issue Release: 2021

1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.

Issue Release: 2020

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.

Issue Release: 2019

BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.

Issue Release: 2019

What are Leukemias?

How Do Synaptic Potentials Integrate?

How is it Performed?

What is the Role of Nervous Tissue?

What are the Steps Involved in Volume Rendering?

How are Immune Responses in Tissues Quantified?

What are Common Diagnostic Criteria in Histology?

What is the FUS-DDIT3 Fusion Gene?

How are Samples Mounted?

How Does AI Enhance Data Recovery in Histology?

Partnered Content Networks

Relevant Topics